ENTERA BIO LTD. Revenue
ENTERA BIO LTD. (ENTX) reported Revenue of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-07
- ENTERA BIO LTD. revenues for the quarter ending 2026-06-30 was $0.00.
- ENTERA BIO LTD. revenues for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. revenues for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. revenues for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. revenues for fiscal 2025 was $42.00K, a 76.80% decline from fiscal 2024.
- ENTERA BIO LTD. revenues for fiscal 2024 was $181.00K.
- ENTERA BIO LTD. revenues for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ENTERA BIO LTD. revenues for fiscal 2022 was $134.00K, a 76.53% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $42.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $42.00K 10-Q · filed 2025-11-14 | $124.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $42.00K 10-Q · filed 2026-08-07 | $124.00K derived: sum of 3 quarters · filed 2026-08-07 | $166.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $42.00K 10-Q · filed 2026-05-08 | $124.00K derived: sum of 2 quarters · filed 2026-05-08 | $166.00K derived: sum of 3 quarters · filed 2026-05-08 | $223.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $124.00K derived: sum of 2 quarters · filed 2026-03-27 | $181.00K derived: sum of 3 quarters · filed 2026-03-27 | $181.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $42.00K 10-Q · filed 2025-11-14 | $99.00K derived: sum of 2 quarters · filed 2025-11-14 | $99.00K 10-Q · filed 2025-11-14 | $99.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $57.00K 10-Q · filed 2025-08-08 | $57.00K 10-Q · filed 2025-08-08 | $57.00K derived: sum of 3 quarters · filed 2025-08-08 | $57.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | $0.00 derived: sum of 3 quarters · filed 2025-05-09 | $0.00 derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $14.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $14.00K derived: sum of 3 quarters · filed 2024-08-09 | $22.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-05 | $14.00K derived: sum of 2 quarters · filed 2024-03-08 | $22.00K derived: sum of 3 quarters · filed 2024-03-08 | $66.00K derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $22.00K derived: sum of 2 quarters · filed 2024-03-08 | $66.00K derived: sum of 3 quarters · filed 2024-03-08 | $134.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $8.00K 10-Q · filed 2023-11-14 | $52.00K derived: sum of 2 quarters · filed 2023-11-14 | $120.00K 10-Q · filed 2023-11-14 | $285.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $44.00K 10-Q · filed 2023-08-11 | $112.00K 10-Q · filed 2023-08-11 | $277.00K derived: sum of 3 quarters · filed 2023-08-11 | $417.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $68.00K 10-Q · filed 2023-05-05 | $233.00K derived: sum of 2 quarters · filed 2023-05-05 | $373.00K derived: sum of 3 quarters · filed 2023-05-05 | $482.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $305.00K derived: sum of 2 quarters · filed 2023-03-31 | $414.00K derived: sum of 3 quarters · filed 2023-03-31 | $571.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $140.00K 10-Q · filed 2022-11-10 | $249.00K derived: sum of 2 quarters · filed 2022-11-10 | $406.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $109.00K 10-Q · filed 2022-08-11 | $266.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $157.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $365.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |